Kraj: Armenia
Język: angielski
Źródło: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
clindamycin (clindamycin phosphate), benzoyl peroxide
Glaxo Operations UK Limited
D10AF51
clindamycin (clindamycin phosphate), benzoyl peroxide
10mg/g+ 50mg/g
gel for external use
15g aluminium tube
Prescription
Registered
2015-10-20
Summary of Product Characteristics Updated 26-Jan-201S I Stiefel I. Name of the medicinal product I g of gel contains: DuacQl) Once Daily 10 mg/g + 50 mg/g Gel 2. Qualitative and quantitative composition 10 mg c\indamycin as clindamycin phosphate 50 mg anhydrous benzoyl peroxide as hydrous benzoyl peroxide For the fu 1\ list of excipients, see section 6.1. 3. Pharmaceutical form Gel White to slightly yellow homogeneous gel 4. Clinical particulars 4.1 Therapeutic indications Duac Once Daily Gel is indicated for the topical treatment of mild to moderate acne vulgaris, particularly inflammatory lesions, in adults and adolescents aged 12 years and above (see sections 4.41and 5.1). Consideration should be given to official guidance on the appropriate use of antibacterial agents. 4.2 Posology and method of administration For cutaneous use only. Posology _Adults_ _and Adolescents_ _(aged_ 12 _years and above)_ Duac Once Daily Gel should be applied once daily in the evening, to the entire affected area. Patients should be advised that excessive application will not im-6fove-effrcacy, but-may increase ; .:JLI£HTLFJC CEHTI(F IW the risk of skin irritation. If excessive dryness or peeling occurseJrfn uen~ J M- Sffi)~~ be reduced or application temporarily interrupted (see section;4;:~)", Ie ~~L_ft'IL:~~. ! C'9M~ • ~ _Ltr.':f,.;~:r::_ _._ _~t>_ _~.(:_ #,-""-, : CGI5 /: /- ~ n . ..?t.,":--.: ! . •• . ". _-oJ._ _i._ I ~;~~: !~'4- APPL . ~:.;,..: . e., .: '.';., _'l) ~~~••_ _~_ _....._ _~._ _'~:JJ._ An effect on inflammatory and non-inflammatory lesions may be seen as early as week 2-5 of treatment (see section 5.1). The safety and efficacy of Duac Once Daily Gel has not been studied beyond 12 weeks in acne vulgaris clinical trials. Treatment with Duac Once Daily Gel should not exceed more than 12 weeks of continuous use. _Paediatric_ _population_ The safety and efficacy ofDuac Once Daily Gel has not been established in children under 12 years of age, therefore Duac Once Daily Gel is not recommended for use in this p Przeczytaj cały dokument